公司资料
Merus 股价、新闻与催化剂
- 股票代码:
- MRUS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Netherlands
股价为何变动
Current closing-price context is not available for MRUS.
公司概览
业务概览
Merus is a clinical-stage antibody company focused on precision oncology and bispecific antibody development. Its platform is built around engineered immunology and cancer programs.
所在地与行业分类
Headquartered in the Netherlands and listed on NASDAQ as an ADR, Merus has a global biotechnology footprint.
商业模式特征
The business depends on clinical data, platform validation, and the ability to create differentiated oncology assets.
生物医药行业定位
Merus is a platform antibody name with meaningful upside if its bispecific science keeps validating clinically.
未来催化剂
- Merus's catalysts are petosemtamab and zenocutuzumab, with the next data updates deciding whether the bispecific oncology story keeps strengthening. The company still needs the next readout to make the platform feel more than promising.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。